Conflicts of Interest Disclosures for AAGP
Board Members, Committee Chairs, and Executive Staff 2009-2010
Board of Directors
Chip Reynolds, President
AAGP Compensation: Receive $10,000 honorarium annually for service as Associate Editor of AJGP. Governance: President of the Board of the American Foundation for Suicide Prevention. Chairman, Sleep Wake Disorders Work Group of the DSM-V Task Force (not compensated). Research Support: (in the form of pharmaceutical supplies) for NIH sponsored research from Forest Laboratories, Pfizer, Bristol-Myers Squibb, Lilly and Wyeth.
Jeffrey Lyness, President-Elect
AAGP Compensation: Honorarium for former contributions to Review Course. Governance: Former program committee member ICGP; member, committee on Award for Research in Geriatric Psychiatry, ACPsych. Research support: NIMH.
Bruce Pollock, Past President
Financial: Serves on the advisory board of Lundbeck Pharmaceuticals and previously for Forest Laboratories (last meeting March 2008). Faculty Member of the Lundbeck International Institute. One time Consultant for Takeda (July 2007) and Wyeth (October 2008).
Research Support: NIH
Allan Anderson, Secretary/Treasurer
AAGP Compensation: Honorarium for review course at annual meeting (in the past). Governance: Serve on APA RBRVS Committee and Alt. Rep to RUC. Research Support: Clinical Trials support from Medivation and Novartis. Financial: Speakers Bureaus – Forest & Novartis.
David Steffens, Secretary/Treasurer-Elect
Consultant to TransForm Pharmaceuticals (a Johnson & Johnson company), has received financial support from Bristol-Myers Squibb for travel expenses related to a presentation at a national meeting, is on the Speaker's Bureau for Forest Pharmaceuticals and Wyeth Pharmaceuticals.
Grant Support: National Institute of Mental Health.
Ike Ahmed, Board Member
Governance: Member of Geriatric Psychiatry Exam writing committee of ABPN; Corresponding member of the Long Term Care Committee of APA; Member of Program Planning Committee of APA; Member of the APA Assembly.
Josepha Cheong, Board Member
AAGP Compensation: As a board member, the AAGP has paid for/in kind travel to Board Meetings. In the past I have received an honorarium as a speaker for programs (while on approved AL from VA position). Governance: Chair, APA Scientific Program Committee; Immediate-past Co-Chair, APA Council on Aging. Employment: Primary employment with the US Government VHA – VA Medical Center; State of Florida – University of Florida.
Laura Dunn, Board Member
Financial: Stock (less than $10,000) in Merck.
Paul Kirwin, Board Member
Nothing to disclose.
Helen Kyomen, Board Member
Governance: As of May 2008, member of the APA Council on Aging. Financial: Consultant: AstraZeneca Pharmaceuticals LP; Bayer Corporation; Bristol-Myers Squibb Company; Merck & Co., Inc.; Eli Lilly and Company; Roche Pharmaceuticals; GlaxoSmithKline; Novartis Pharmaceuticals Corporation; UCB Pharma; Wyeth-Ayerst Laboratories; Pfizer, Inc. Grant/Research Support: Bayer Corporation; Bristol-Myers Squibb Company; Eli Lilly and Company; Roche Pharmaceuticals; UCB Pharma; Wyeth-Ayerst Laboratories; Pfizer, Inc.; NIH Institute; The John A. Hartford Foundation; National Institute on Aging; Veterans Administration.
Melinda Lantz, Board Member
Financial: Bristol-Myers Squibb – speakers bureau. Research Support: Genentech – research support.
Maria Llorente, Board Member
Governance: Member, Board of Directors, American Psychiatric Foundation. Chair, Ethnic Minority Elderly Committee, APA.
Constantine Lyketsos, Board Member
Financial: Consultant/Advisor to Astra-Zeneca, Glaxo-Smith Kline, Eisai, Novartis, Forest, Supernus, Adlyfe, Takeda, Wyeth, Lundbeck Merz, and Lilly. Honorarium or travel support from: Pfizer, Forest, Glaxo-Smith-Kline, Health Monitor. No stock in pharma other than via mutual funds I do not control.
Governance: Past President, Academy of Psychosomatic Medicine.
Grant Support: (Research or CME) NIMH, NIA, Associated Jewish Federation of Baltimore, Weinberg Foundation, Forest, Glaxo-Smith-Kline, Eisai, Pfizer, Astra-Zeneca, Lilly, Ortho-McNeil, Bristol-Myers, Novartis.
David Oslin, Board Member
Research Support: Research funding from NIH, the Department of Veterans Affairs, and the Commonwealth of Pennsylvania.
Robert Sweet, Board Member
Governance: Education & Training Committee Member, ACNP. Member, Board of Directors, Jewish Association on Aging, Pittsburgh. Financial: Grant Support NIMH, NIA, VAHS.
Keith Stowell, MIT Board Member
Governance: Member of APA Board of Trustees (2007-08); Member of APA Committee on Access and Effectiveness on psychiatric services for the elderly, Member of APA Committee on Long Term Care and Treatment of the Elderly (2008-09); Member of APA Committee on Access & Effectiveness of Psychiatric Services for the Elderly (2006-08).
Committee Chairs
Jordan Karp, Diversity Committee, Co-Chair
Financial: Corcept: Stock holder. Pfizer, Novartis: Honoraria for unrestricted educational activity. Eli Lilly, Theravance: Advisor. Research Support: Receive research support in the form of medication supplies for an investigator initiated trial from Eli Lilly.
Susan Schultz, Annual Meeting Program Committee Chair
Research Support: Research support from an Alzheimer’s Disease Cooperative Study collaboration with Baxter Healthcare.
Financial: American Journal of Psychiatry, compensation for editorial duties
Eric Lenze, Annual Meeting Program Committee Chair (2011)
Financial: Consultant, Fox Learning Systems (present) and Veterans Medical Research Foundation (past). GLG consulting – some ad hoc consulting (<$1000 per year). Research Grants: Investigator-initiated grants from Forest (present), Pfizer (past), OrthoMcNeill Neurologics (past).
Barbara Kamholz, CME Committee Chair
Nothing to disclose.
Paul Newhouse, Research Committee Chair
Financial: Consultant – NeuroDerm; Speakers Bureau – Pfizer. Research Support: Pfizer, Epix, Lilly, Targacept.
Daniel Sewell, Education Committee Chair
Financial: Until the end of 2007, partner owned a small amount of common stock in Forest Laboratories, Inc.; Member of the Medical Advisory Board, The Health Care Group, Inc., a corporation which provides residential care to individuals living with dementia, for which I receive an honorarium; President, Traveling Educational Presentation, Inc., an s-corp which pays me for creating and delivering educational presentations; Assistant Director for the Physician-Educator Tract for the John A. Hartford Foundation Center of Excellence (CoE) in Geriatric Psychiatry at UCSD. This position provides 5% of my salary as well as helps with CoE-related travel expenses. AAGP: Program Chair AAGP Education Committee; In the past I have received honoraria for being a faculty member of the AAGP-sponsored board review course in geriatric psychiatry.
Robert Greenberg, Clinical Practice Committee Co-Chair
Governance: Member of the Board of Directors, Association for Convulsive Therapy.
Maureen Nash, Clinical Practice Committee Co-Chair
Epocrates survey income (less than $1000 per year).
AAGP: In 2005 and 2006 I was paid occasionally as an ad-hoc reviewer for the AAGP Abstract Service. In 2006, this was less than $1000.00.
Karen Blank, Public Policy & Communications Committee Chair
Nothing to disclose.
Executive Staff
Chris deVries, CEO
Paid annual salary by AAGP.
Marj Vanderbilt, Deputy Executive Director/Director of Government Affairs
Paid annual salary by AAGP.
Belinda D’Agostino, Director of Finance and Administration
Paid annual salary by AAGP.
Carrie Stankiewicz, Director of Governance
Paid annual salary by AAGP.
Karen Kanefield, Director of Education and Professional Development
Paid annual salary by AAGP.
|
